Shi, Xiaohan
Guo, Shiwei
Duan, Qiaonan
Zhang, Wei
Gao, Suizhi
Jing, Wei
Jiang, Guojuan
Kong, Xiangyu
Li, Penghao
Li, Yikai
Teng, Chuanqi
Xu, Xiaoya
Chen, Sheng
Nian, Baoning
Li, Zhikuan
Zhong, Chaoliang
Yang, Xiaolu
Zhu, Guangyu
Du, Yiqi
Zhang, Dadong
Jin, Gang
Funding for this research was provided by:
National Key Research and Development Program of China (2019YFC1315900)
National Natural Science Foundation of China (82303496)
Shanghai Science and Technology Committee (20511101200)
Shanghai Shenkang Hospital Development Center (SHDC2020CR2001A)
Article History
Received: 1 March 2024
Accepted: 8 May 2024
First Online: 15 May 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki. This study was approved by the Ethics Committee of Changhai Hospital (CHEC2018-112). All participants provided signed written informed consent to use their blood samples and clinical data.
: Not applicable.
: All authors affiliated with 3D Medicines Inc. are current or former employees. No potential conflicts of interest were disclosed by the other authors.